Evaluation of anticonvulsant and nootropic effect of ondansetron in mice

Human and Experimental Toxicology

Volumn 31, Issue 9, 2012, Pages 905-912

  Jain, S ^a   Agarwal, N B ^b   Mediratta, P K ^a   Sharma, K K ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

5 HT3 receptor; electroshock; ondansetron; step down latency; transfer latency

Indexed keywords

NOOTROPIC AGENT; ONDANSETRON; PENTETRAZOLE; PHENYTOIN; PIRACETAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; COGNITION; CONTROLLED STUDY; ELECTRIC SHOCK; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEIZURE; SEIZURE THRESHOLD; SINGLE DRUG DOSE; TREATMENT DURATION;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; ELECTROSHOCK; MALE; MICE; NOOTROPIC AGENTS; ONDANSETRON; PENTYLENETETRAZOLE; SEIZURES; SEROTONIN ANTAGONISTS;

MUS;

EID: 84866488650     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112436406     Document Type: Article

References (58)

1. Loscher W, Schmidt D. New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res. 2004 ; 60: 77-159
2. French JA. Refractory epilepsy: clinical overview. Epilepsia. 2007 ; 48: 3-7
3. Masukawa LM, Higashima M, Hart GJ, Spencer DD, O'Connor MJ. NMDA receptor activation during epileptiform responses in the dentate gyrus of epileptic patients. Brain Res. 1991 ; 562: 176-180
4. Schwartzkorin PA. Cellular electrophysiology of human epilepsy. Epilepsy Res. 1994 ; 17: 185-192
5. Trindade-Filho EM, de Castro-Neto EF, de Carvalho RA, Lima E, Scorza FA, Amado D, et al. Serotonin depletion effects on the pilocarpine model of epilepsy. Epilepsy Res. 2008 ; 82: 194-199
6. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 1994 ; 46: 157-203
7. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999 ; 38: 1083-1152
8. Page IH. Serotonin (5-hydroxytryptamine). Physiol Rev. 1954 ; 34: 563-588
9. Ye JH, Ponnudurai R, Schaefer R. Ondansetron: a selective 5-HT3 receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev. 2001 ; 7: 199-213
10. Dailey JW, Yan QS, Adams-Curtis LE, Ryu JR, Ko KH, Mishra PK, et al. Neurochemical correlates of anti-epileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci. 1996 ; 58: 259-266
11. Wada Y, Shiraishi J, Nakamura M, Koshino Y. Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res. 1997 ; 747: 338-342
12. Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonin and epilepsy. J Neurochem. 2007 ; 100: 857-873
13. Perii D, Atrac DS. The role of 5-HT7 receptors in the control of seizures. Brain Res. 2007 ; 1141: 48-55
14. Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol. 1988 ; 94: 397-412
15. Cunningham RS. 5-HT3 receptor antagonists: a review of pharmacology and clinical efficacy. Oncol Nurs Forum. 1997 ; 24: 33-40
16. Wilde MI, Markham A. Ondansetron; a review of its pharmacology and preliminary clinical findings in novel applications. Drugs. 1996 ; 52: 773-794
17. Swain TR, Mohanty M. Antiepileptic action of ondansetron. Indian J Pharmacol. 1999 ; 31: 157
18. Balakrishnan S, Bhargava VK, Pandhi P. Anticonvulsant profile of ondansetron in rats. Epilepsy Behav. 2000 ; 1: 22-26
19. Altman HJ, Normile HJ. What is the nature of the role of the serotonergic nervous system in learning and memory? Prospects for development of an effective treatment strategy for senile dementia. Neurobiol Aging. 1988 ; 9: 627-638
20. McEntee WJ, Crook TH. Serotonin, memory, and the aging brain. Psychopharmacology. 1991 ; 103: 143-149
21. Meneses A.. 5-HT system and cognition. Neurosci Biobehav Rev. 1999 ; 23: 1111-1125
22. Barnes JM, Costall B, Coughlan J, Domeney AM, Gerrard PA, Kelly ME, et al. The effects of ondansetron, a 5-HT3 receptor antagonist on cognition in rodents and primates. Pharmacol Biochem Behav. 1990 ; 35: 955-962
23. Chugh Y, Saha N, Sankaranarayanan A, Datta H. Enhancement of memory retrieval and attenuation of scopolamine-induced amnesia following administration of 5-HT3 antagonist ICS 205-930. Pharmacol Toxicol. 1991 ; 69: 105-106
24. Fontana DJ, Wong EHF, Clark RD, Bonhaus D, Leung E, Eglen RM Chicago, IL: Abstracts, Third IUPHAR Satellite Meeting on Serotonin ; 1994: p. 57.
25. Kitano Y, Usui C, Takasuna K, Hirohashi M, Nomura M.. Increasing current electroshock seizure test. A new method for assessment of anti- and proconvulsant activities of drugs in mice. J Phamacol Toxicol Methods. 1996 ; 35: 25-29
26. Marwah R, Pal SN, Pillai KK. Effect of fluoxetine on increasing current electroshock seizures (ICES) in mice. Indian J Pharmacol. 1999 ; 31: 350-353
27. Bharal N, Pillai KK, Vohora D. Effects of sparfloxacin on CNS functions and urinary hydroxyproline in mice. Pharmacol Res. 2006 ; 54: 111-117
28. Ukai M, Miura M, Kameyama T. Effects of galanin on passive avoidance response, elevated plus-maze learning, and spontaneous alternation performance in mice. Peptides. 1995 ; 16: 1283-1286
29. Reddy DS, Kulkarni SK. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res. 1998 ; 791: 108-116
30. Riedel WJ. Cognitive changes after acute tryptophan depletion: what can they tell us?. Psychol Med. 2004 ; 34: 3-8
31. Schmitt JA, Wingen M, Ramaekers JG, Evers EA, Riedel WJ. Serotonin and human cognitive performance. Curr Pharm Des. 2006 ; 12: 2473-2486
32. Buhot MC. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol. 1997 ; 7: 243-254
33. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev. 1992 ; 72: 165-229
34. Browning RA, Hoffman WE, Simonton RL. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxy-tryptamine: role of serotonergic neurones. Ann N Y Acad Sci. 1978 ; 305: 437-456
35. Wada Y, Nakamura M, Hasegawa H, Yamaguchi N. Intrahippocampal injection of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci Lett. 1993 ; 159: 179-182
36. Brennan TJ, Seeley WW, Kilgard M, Schreiner CE, Tecott LH. Sound-induced seizures in serotonin 5-HT2C receptor mutant mice. Nat Genet. 1997 ; 16: 387-390
37. Wada Y, Shiraishi J, Nakamura M, Koshino Y. Biphasic action of the histamine precursor L-histidine in the rat kindling model of epilepsy. Neurosci Lett. 1996 ; 204: 205-208
38. Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science. 1991 ; 254: 432-437
39. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PP, Middlemiss DN, et al. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986 ; 25: 563-576
40. Isaac M. Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs. Curr Top Med Chem. 2005 ; 5: 59-67
41. William H, Theodore MD. Does serotonin play a role in epilepsy?. Epilepsy Curr. 2003 ; 3: 173-177
42. Wada Y, Shiraishi J, Nakamura M, Koshino Y. Effects of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide in the rat kindling model of epilepsy. Brain Res. 1997 ; 759 (2). 313-316
43. Semenova TP, Ticku MK. Effects of 5-HT receptor antagonists on seizure suspectibility and locomotor activity in DBA/2 mice. Brain Res. 1992 ; 588: 229-236
44. Ramesha ST, Asada M, Dhamanigia SS, Prasad VS. Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers. Fundam Clin Pharmacol. 2009 ; 23: 303-309
45. Stefaski R, Paejko W, Bidziski A, Kostowski W, Panik A. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT receptor antagonists. Neuropharmacology. 1993 ; 32: 987-993
46. Ye JH, Hunt T, Wu WH, McArdle JJ. Ondansetron modulates GABA (A) current of rat central nervous system neurons. Eur J Pharmacol. 1997 ; 337: 87-91
47. Chen Q, Lee TH, Wetsel WC, Sun QA, Liu Y, Davidson C, et al. Reversal of cocaine sensitization-induced behavioral sensitization normalizes GAD67 and GABAA receptor alpha2 subunit expression, and PKC zeta activity. Biochem Biophys Res Commun. 2007 ; 356: 733-738
48. Davidson C, Gopalan R, Ahn C, Chen Q, Mannelli P, Patkar AA, et al. Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal. Eur J Pharmacol. 2007 ; 565: 113-118
49. Kasture SB, Kasture VS. Effect of some serotonergic agents on lithium-pilocarpine model of status epilepticus in rats. Indian J Pharmacol. 1999 ; 31: 370-372
50. Ye JH, Schaefer R, Wu WH, Liu PL, Zbuzek VK, Mcardle JJ. Inhibitory effect of ondansetron on glycine response of dissociated rat hippocampal neurons. J Pharmacol Exp Ther. 1999 ; 290: 104-111
51. Klein RL, Sanna E, McQuilkin SJ, Whiting PJ, Harris RA. Effects of 5-HT3 receptor antagonists on binding and function of mouse and human GABAA receptors. Eur J Pharmacol. 1994 ; 268: 237-246
52. Squires RF, Saederup E. Clozapine's antipsychotic effects do not depend on blockade of 5HT3 receptors. Neurochem Res. 1999 ; 24: 659-667
53. Meneses A. 5-HT receptors as targets for drugs in the treatment of learning and memory dysfunctions. Curr Res Serotonin. 1998 ; 3: 214-235
54. Meneses A. Physiological, pathophysiological and therapeutic roles of 5-HT systems in learning and memory. Rev Neurosci. 1998 ; 9: 1-13
55. Hong E, Meneses A. Systemic injection of p-chloroamphetamine eliminates the effect of the 5-HT3 compounds on learning. Pharmacol Biochem Behav. 1996 ; 53: 765-769
56. Domeney AM, Costall B, Gerrard PA. The effect of ondansetron on cognitive performance in the marmoset. Pharmacol Biochem Behav. 1991 ; 38: 169-175
57. Cassel JC, Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience. 1995 ; 69: 1-41
58. Pitsikas N, Borsini F. Different effects of tropisetron and ondansetron in learning and memory paradigms. Pharmacol Biochem Behav. 1997 ; 56: 571-576